Literature DB >> 22448904

European outbreaks of atypical myopathy in grazing equids (2006-2009): spatiotemporal distribution, history and clinical features.

G van Galen1, C Marcillaud Pitel, C Saegerman, F Patarin, H Amory, J D Baily, D Cassart, V Gerber, C Hahn, P Harris, J A Keen, N Kirschvink, L Lefere, B McGorum, J M V Muller, M T J E Picavet, R J Piercy, K Roscher, D Serteyn, L Unger, J H van der Kolk, G van Loon, D Verwilghen, C M Westermann, D M Votion.   

Abstract

REASONS FOR PERFORMING STUDY: Improved understanding of the epidemiology of atypical myopathy (AM) will help to define the environmental factors that permit or support the causal agent(s) to exert toxicity.
OBJECTIVES: This European survey of AM aimed to describe spatiotemporal distribution, survival, clinical signs, circumstances in which AM develops and its different expressions between countries and over time.
METHODS: The spatiotemporal distribution, history and clinical features of AM cases reported to the Atypical Myopathy Alert Group from 2006 to 2009 were described. Comparisons of data from the most severely affected countries and from the large outbreaks were made with Fisher's exact and Welch's tests with Bonferroni correction.
RESULTS: Of 600 suspected cases, 354 met the diagnostic criteria for confirmed or highly probable AM. The largest outbreaks occurred during the autumns of 2006 and 2009 in Belgium, France and Germany. For the first time, donkeys, zebras and old horses were affected, and clinical signs such as gastrointestinal impaction, diarrhoea, penile prolapse, buccal ulceration and renal dysfunction were observed. Affected horses spent >6 h/day on pastures that almost always contained or were surrounded by trees. The latency period was estimated at up to 4 days. Overall survival rate was 26%. Although differences between countries in affected breeds, body condition, horse management and pasture characteristics were recognised, the common presenting clinical signs and mortality were similar between countries. CONCLUSIONS AND POTENTIAL RELEVANCE: This study describes new data on case details, history and clinical course of AM that is of preventive, diagnostic and therapeutic value. However, the true impact of the findings of this study on the development of or severity of AM should be tested with case-control studies.
© 2012 EVJ Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22448904     DOI: 10.1111/j.2042-3306.2012.00556.x

Source DB:  PubMed          Journal:  Equine Vet J        ISSN: 0425-1644            Impact factor:   2.888


  13 in total

1.  Atypical myopathy in Père David's deer (Elaphurus davidianus) associated with ingestion of hypoglycin A.

Authors:  Carolin Bunert; Sandra Langer; Dominque M Votion; François Boemer; Anja Müller; Kerstin Ternes; Annette Liesegang
Journal:  J Anim Sci       Date:  2018-07-28       Impact factor: 3.159

2.  Acquired multiple acyl-CoA dehydrogenase deficiency and marked selenium deficiency causing severe rhabdomyolysis in a horse.

Authors:  Diego E Gomez; Stephanie J Valberg; K Gary Magdesian; Paul E Hanna; Jeanne Lofstedt
Journal:  Can Vet J       Date:  2015-11       Impact factor: 1.008

3.  Hypoglycin A Content in Blood and Urine Discriminates Horses with Atypical Myopathy from Clinically Normal Horses Grazing on the Same Pasture.

Authors:  M Bochnia; J Ziegler; J Sander; A Uhlig; S Schaefer; S Vollstedt; M Glatter; S Abel; S Recknagel; G F Schusser; M Wensch-Dorendorf; A Zeyner
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

4.  Hypoglycin A concentrations in seeds of Acer pseudoplatanus trees growing on atypical myopathy-affected and control pastures.

Authors:  L Unger; A Nicholson; E M Jewitt; V Gerber; A Hegeman; L Sweetman; S Valberg
Journal:  J Vet Intern Med       Date:  2014-05-26       Impact factor: 3.333

5.  Acylcarnitines profile best predicts survival in horses with atypical myopathy.

Authors:  François Boemer; Johann Detilleux; Christophe Cello; Hélène Amory; Christel Marcillaud-Pitel; Eric Richard; Gaby van Galen; Gunther van Loon; Laurence Lefère; Dominique-Marie Votion
Journal:  PLoS One       Date:  2017-08-28       Impact factor: 3.240

6.  Hypoglycin A in Cow's Milk-A Pilot Study.

Authors:  Mandy Bochnia; Jörg Ziegler; Maren Glatter; Annette Zeyner
Journal:  Toxins (Basel)       Date:  2021-05-26       Impact factor: 4.546

7.  The story of equine atypical myopathy: a review from the beginning to a possible end.

Authors:  Dominique-Marie Votion
Journal:  ISRN Vet Sci       Date:  2012-11-14

8.  Atypical myopathy in 2 Bactrian camels.

Authors:  Manuela Hirz; Henrike A Gregersen; Johannes Sander; Dominique M Votion; Anne Schänzer; Kernt Köhler; Christiane Herden
Journal:  J Vet Diagn Invest       Date:  2021-06-07       Impact factor: 1.569

9.  Hypoglycin A Concentrations in Maple Tree Species in the Netherlands and the Occurrence of Atypical Myopathy in Horses.

Authors:  C M Westermann; R van Leeuwen; L W D van Raamsdonk; H G J Mol
Journal:  J Vet Intern Med       Date:  2016-03-20       Impact factor: 3.333

10.  Detection of equine atypical myopathy-associated hypoglycin A in plant material: Optimisation and validation of a novel LC-MS based method without derivatisation.

Authors:  Sonia González Medina; Carolyne Hyde; Imogen Lovera; Richard J Piercy
Journal:  PLoS One       Date:  2018-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.